General
Preferred name
RACLOPRIDE
Synonyms
S(+)-Raclopride L-tartrate ()
Meglitinides ()
Raclopride84225-95-6 ()
RACLOPRIDE C 11 ()
[3H]raclopride ()
(11c)-raclopride ()
Raclopride c-11 ()
P&D ID
PD002893
CAS
84225-95-6
97849-54-2
104953-11-9
Tags
drug candidate
natural product
drug
available
Drug indication
Psychotic disorder
Type-2 diabetes
Radioactive Agent
Drug Status
investigational
approved
Max Phase
Phase 1
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Selective P2Y12 antagonist
(Tocris Bioactive Compound Library)
DESCRIPTION
Potent, selective D2/D3 antagonist
(Tocriscreen Plus)
DESCRIPTION
Potent, selective D2/D3 antagonist
(Tocriscreen Total)
DESCRIPTION
Selective D2 dopamine receptor antagonist
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
22
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMAP Approved Drugs
LOPAC library
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
346.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
1
cLogP
2.92
TPSA
61.8
Fraction CSP3
0.53
Chiral centers
1.0
Largest ring
6.0
QED
0.86
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Selectivity
D2
Primary Target
Non-selective Dopamine
MOA
Antagonist
Dopamine D2 Antagonists
Dopamine D3 Antagonists
Dopamine Receptor antagonist
Member status
member
Target
DRD2, DRD3, HTR1A
Dopamine Receptor
Pathway
GPCR/G protein
Neuronal Signaling
Source data